88 related articles for article (PubMed ID: 22555171)
1. Targeting the retroviral ribonuclease H by rational drug design.
Moelling K
AIDS; 2012 Oct; 26(16):1983-93. PubMed ID: 22555171
[TBL] [Abstract][Full Text] [Related]
2. Drug targeting of HIV-1 RNA.DNA hybrid structures: thermodynamics of recognition and impact on reverse transcriptase-mediated ribonuclease H activity and viral replication.
Li TK; Barbieri CM; Lin HC; Rabson AB; Yang G; Fan Y; Gaffney BL; Jones RA; Pilch DS
Biochemistry; 2004 Aug; 43(30):9732-42. PubMed ID: 15274628
[TBL] [Abstract][Full Text] [Related]
3. Uncovering the complexities of retroviral ribonuclease H reveals its potential as a therapeutic target.
Klarmann GJ; Hawkins ME; Le Grice SF
AIDS Rev; 2002; 4(4):183-94. PubMed ID: 12555693
[TBL] [Abstract][Full Text] [Related]
4. Reduction of gene expression by a hairpin-loop structured oligodeoxynucleotide: alternative to siRNA and antisense.
Kwok T; Heinrich J; Jung-Shiu J; Meier MG; Mathur S; Moelling K
Biochim Biophys Acta; 2009 Oct; 1790(10):1170-8. PubMed ID: 19505533
[TBL] [Abstract][Full Text] [Related]
5. Coupling of reverse transcriptase and RNase H during HIV-1 replication.
Wöhrl BM; Moelling K
Behring Inst Mitt; 1991 Jul; (89):100-7. PubMed ID: 1718256
[TBL] [Abstract][Full Text] [Related]
6. Ribonuclease H: from discovery to 3D structure.
Crouch RJ
New Biol; 1990 Sep; 2(9):771-7. PubMed ID: 2177653
[TBL] [Abstract][Full Text] [Related]
7. Premature activation of the HIV RNase H drives the virus into suicide: a novel microbicide?
Broecker F; Andrae K; Moelling K
AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1397-403. PubMed ID: 22931114
[TBL] [Abstract][Full Text] [Related]
8. Relationship between retroviral replication and RNA interference machineries.
Moelling K; Matskevich A; Jung JS
Cold Spring Harb Symp Quant Biol; 2006; 71():365-8. PubMed ID: 17381318
[TBL] [Abstract][Full Text] [Related]
9. Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.
Julias JG; Ferris AL; Boyer PL; Hughes SH
J Virol; 2001 Jul; 75(14):6537-46. PubMed ID: 11413321
[TBL] [Abstract][Full Text] [Related]
10. Polyamide nucleic acid targeted to the primer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcription.
Lee R; Kaushik N; Modak MJ; Vinayak R; Pandey VN
Biochemistry; 1998 Jan; 37(3):900-10. PubMed ID: 9454580
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of HIV-1 reverse transcriptase (HIV-1 RT) RNase H by small RNA hairpins and dumbbells.
Hannoush RN; Carriero S; Min KL; Damha MJ
Chembiochem; 2004 Apr; 5(4):527-33. PubMed ID: 15185377
[TBL] [Abstract][Full Text] [Related]
12. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
Gao HQ; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
[TBL] [Abstract][Full Text] [Related]
13. Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excision.
Nikolenko GN; Palmer S; Maldarelli F; Mellors JW; Coffin JM; Pathak VK
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2093-8. PubMed ID: 15684061
[TBL] [Abstract][Full Text] [Related]
14. Recognition of internal cleavage sites by retroviral RNases H.
Schultz SJ; Zhang M; Champoux JJ
J Mol Biol; 2004 Nov; 344(3):635-52. PubMed ID: 15533434
[TBL] [Abstract][Full Text] [Related]
15. RNase H-mediated retrovirus destruction in vivo triggered by oligodeoxynucleotides.
Matzen K; Elzaouk L; Matskevich AA; Nitzsche A; Heinrich J; Moelling K
Nat Biotechnol; 2007 Jun; 25(6):669-74. PubMed ID: 17546028
[TBL] [Abstract][Full Text] [Related]
16. Using pyrrolo-deoxycytosine to probe RNA/DNA hybrids containing the human immunodeficiency virus type-1 3' polypurine tract.
Dash C; Rausch JW; Le Grice SF
Nucleic Acids Res; 2004; 32(4):1539-47. PubMed ID: 15004241
[TBL] [Abstract][Full Text] [Related]
17. Oligonucleotide-mediated retroviral RNase H activation leads to reduced HIV-1 titer in patient-derived plasma.
Heinrich J; Mathur S; Matskevich AA; Moelling K
AIDS; 2009 Jan; 23(2):213-21. PubMed ID: 19098491
[TBL] [Abstract][Full Text] [Related]
18. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits.
Sevilya Z; Loya S; Hughes SH; Hizi A
J Mol Biol; 2001 Aug; 311(5):957-71. PubMed ID: 11531332
[TBL] [Abstract][Full Text] [Related]
19. 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro.
Tramontano E; Esposito F; Badas R; Di Santo R; Costi R; La Colla P
Antiviral Res; 2005 Feb; 65(2):117-24. PubMed ID: 15708638
[TBL] [Abstract][Full Text] [Related]
20. Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication.
Naeger LK; Margot NA; Miller MD
Antivir Ther; 2001 Jun; 6(2):115-26. PubMed ID: 11491416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
